Skip to main content
Caplight Logo









Vasa Therapeutics

Vasa Therapeutics

Private
Encinitas, CaliforniaHealthcare & Life Scienceshttps://vasatherapeutics.com/

Last Round

Seed

Jan 3, 2024

Total Funding Raised

$11M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vasa Therapeutics is a biopharmaceutical company that discovers and develops therapeutics targeting the pathophysiology of cardiovascular aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

biotechnologydrug discoveryCAMKII inhibitorscardiovascular diseasemetabolic diseaseAI drug discoveryin silico drug designmedicinal chemistrybiotech R&Dpharmaceutical licensingpreclinical developmentAI-driven therapeuticscomputational biologysmall molecule inhibitorsbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vasa Therapeutics Comparables

Compare Vasa Therapeutics with similar companies based on industry and business-model similarity.

Vasa Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardiaTec
88%
Antlia Bioscience, Inc.
73%
POLYGON Therapeutics
72%

Vasa Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 3, 2024

Key People

Founding team and executive leadership

Artur Plonowski

CEO and Co-Founder

Founding Team

Michael F. Geremia

CFO

Executive Team

Vasa Therapeutics Investors

Notable investors and investment history

Vasa Therapeutics investors
InvestorRounds
SeedFolioSeed
Orphinic Scientific SASeed
NuFundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    Partnered with Eli Lilly's 'tunelab' for AI/ML platform.

  • Feb 12, 2026

    Attended the 36th Annual Oppenheimer Life Sciences Conference.

Vasa Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vasa Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vasa Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEncinitas, California
Employee Range14
Year Founded2019
Last FundingJan 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?